Research Topics
Species | S Z GoldhaberSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Venous thromboembolism: epidemiology and magnitude of the problemSamuel Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, USA
Best Pract Res Clin Haematol 25:235-42. 2012....
Pulmonary embolism and deep vein thrombosisSamuel Z Goldhaber
Brigham and Women s Hospital, Department of Medicine, Harvard Medical School, Cardiovascular Division, Boston, MA 02115, USA
Lancet 379:1835-46. 2012..In this Seminar, we discuss pulmonary embolism and deep vein thrombosis of the legs...
Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolismSamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA
Circulation 110:e445-7. 2004
Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction: proSamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA
Arch Intern Med 165:2197-9; discussion 2204-5. 2005
Low intensity warfarin anticoagulation is safe and effective as a long-term venous thromboembolism prevention strategySamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
J Thromb Thrombolysis 21:51-2. 2006....
Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxisSamuel Z Goldhaber
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
Chest 122:1933-7. 2002..At Brigham and Women's Hospital, VTE after craniotomy for brain tumor is the leading cause of deep vein thrombosis (DVT) and pulmonary embolism (PE) among patients hospitalized for conditions other than VTE...
Cardiology patient pages. Treatment of blood clotsSamuel Z Goldhaber
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA
Circulation 106:e138-40. 2002
Gastrointestinal complications of dual antiplatelet therapyNeelima G Vallurupalli
Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA
Circulation 113:e655-8. 2006
Acute pulmonary embolism: risk stratificationSamuel Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Pathophysiol Haemost Thromb 35:153-6. 2006..When high-risk patients are identified,they can be triaged for urgent or emergent therapy, usually prior to developing overt hypotension and cardiogenic shock...
Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosisSamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, Mass 02115, USA
Circulation 108:2726-9. 2003
Acute pulmonary embolism: part II: risk stratification, treatment, and preventionSamuel Z Goldhaber
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA
Circulation 108:2834-8. 2003
Thrombolysis in submassive pulmonary embolismS Z Goldhaber
Cardiovascular Division, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, Boston, MA, USA
J Thromb Haemost 2:1473-4; discussion 1474-8. 2004
How chest CT for the diagnosis of pulmonary embolism (PE) has changed my professional life: reflections from a PE doctorSamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Semin Roentgenol 40:8-10. 2005
DVT Prevention: what is happening in the "real world"?Samuel Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Semin Thromb Hemost 29:23-31. 2003..We will conclude by posing 10 questions for future research on this topic...
Prevention of venous thromboembolism among hospitalized medical patientsSamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA
Circulation 111:e1-3. 2005
Pulmonary embolismSamuel Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Lancet 363:1295-305. 2004..After hospital discharge, prophylaxis should continue for about a month for patients at high risk of thromboembolism...
Prevention of recurrent idiopathic venous thromboembolismSamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
Circulation 110:IV20-4. 2004..Avenues of investigation currently being evaluated include measurement of d-dimer levels, examination of residual venous thrombosis on ultrasound, and application of risk nomograms...
Pulmonary embolism after coronary artery bypass graftingSamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis St, Boston, Mass 02115, USA
Circulation 109:2712-5. 2004
Epidemiology of pulmonary embolismS Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Semin Vasc Med 1:139-46. 2001..The two most common genetic mutations that predispose to VTE are the factor V Leiden and the prothrombin gene. VTE can be precipitated by oral contraceptives, pregnancy, or hormone replacement therapy...
Cardiology patient pages. Pulmonary embolism and deep vein thrombosisSamuel Z Goldhaber
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA
Circulation 106:1436-8. 2002
Modern treatment of pulmonary embolismS Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Eur Respir J Suppl 35:22s-27s. 2002..Fortunately the current tools for risk stratification provide an "early window" for prognostication and can help the coordination of a definitive treatment plan with optimal results...
Echocardiography in the management of pulmonary embolismSamuel Z Goldhaber
Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Ann Intern Med 136:691-700. 2002..Further research will clarify and define more precisely the utility and limitations of echocardiography in the management of pulmonary embolism...
Advanced treatment strategies for acute pulmonary embolism, including thrombolysis and embolectomyS Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Thromb Haemost 7:322-7. 2009..Our 'new approach' uses advanced treatment strategies in addition to anticoagulation for those pulmonary embolism patients deemed to be at high risk for a poor outcome...
Management of deep venous thrombosis and pulmonary embolismS Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts, USA
Clin Cornerstone 2:47-58; quiz 59-64. 2000..Among patients with massive DVT or hemodynamically unstable PE, thrombolysis, thrombectomy, and embolectomy (often performed in an interventional angiography laboratory) are being used with increasing skill and improved outcomes...
Diagnosis of pulmonary embolismS Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts, USA
Clin Cornerstone 2:38-46. 2000..With a 3-stage approach consisting of (1) clinical evaluation; (2) nonimaging laboratory tests; and (3) imaging tests, PE can often be quickly detected with a definitive evaluation...
Diagnosis of deep venous thrombosisS Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts, USA
Clin Cornerstone 2:29-37. 2000..Once DVT is suspected, a workup can proceed rapidly and accurately to resolve the diagnostic issue...
Risk factors for venous thromboembolismSamuel Z Goldhaber
Harvard Medical School, Venous Thromboembolism Research Group, Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
J Am Coll Cardiol 56:1-7. 2010..Because approximately 3 of every 4 pulmonary embolism and DVT events occur outside the hospital setting, patients should also be assessed for persistent high-risk of VTE at the time of hospital discharge...
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patientsSamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 365:2167-77. 2011..We hypothesized that extended prophylaxis with apixaban would be safe and more effective than short-term prophylaxis with enoxaparin...
Treatment of pulmonary thromboembolismS Z Goldhaber
Department of Medicine Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Intern Med 38:620-5. 1999..Finally, the availability of low molecular weight heparins broadens our options for pharmacologic management...
Thrombolysis in pulmonary embolism: a debatable indicationS Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston 02115, USA
Thromb Haemost 86:444-51. 2001..Future clinical trials will require multicenter collaboration and focus on clinically relevant endpoints such as reduction of mortality and recurrent venous thromboembolism...
New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatmentS Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Chest 118:1680-4. 2000..Therefore, among hospitalized patients, the development of VTE is thought to occur in the context of omitted prophylaxis...
Preventing pulmonary embolism and deep vein thrombosis: a 'call to action' for vascular medicine specialistsS Z Goldhaber
Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA 02115, USA
J Thromb Haemost 5:1607-9. 2007
Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolismJoshua A Beckman
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts, USA
Thromb Haemost 89:953-8. 2003..6 days) (p = 0.001). Following our study we can conclude that extended 3-month treatment with enoxaparin as monotherapy for symptomatic, acute pulmonary embolism is feasible and warrants further study in a large clinical trial...
Unsolved issues in the treatment of pulmonary embolismS Z Goldhaber
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Thromb Res 103:V245-55. 2001..Despite the high rate of recurrent venous thrombosis after discontinuation of anticoagulation, there are currently insufficient data to recommend indefinite warfarin therapy...
Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trialM Cushman
Department of Medicine, University of Vermont, Burlington, VT 05446, USA
J Thromb Haemost 4:2199-203. 2006..In some but not all studies, men with venous thrombosis had a higher risk of recurrence than women. Information on women with initial hormone-related thrombosis is scant...
Venous thromboembolism in patients with active cancerAli Seddighzadeh
Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Thromb Haemost 98:656-61. 2007..Future studies should focus on ways to improve implementation of prophylaxis in cancer patients and to further define the indications, efficacy, and safety of inferior vena caval filters in this population...
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolismS Shrivastava
Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, MA, USA
J Thromb Haemost 4:1208-14. 2006..CONCLUSIONS: Among patients with idiopathic VTE, measurement of D-dimer, but not FVIIIc, might be useful for risk stratification. The efficacy of extended low-intensity warfarin therapy did not vary by biomarker level...
Upper-extremity deep vein thrombosis: a prospective registry of 592 patientsHylton V Joffe
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA
Circulation 110:1605-11. 2004..Our findings identify deficiencies in our current understanding and the prophylaxis of UEDVT and generate hypotheses for future research efforts...
Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequentGregory Piazza
Cardiovascular Division, Beth Israel Deaconess Medical Center, 1 Deaconess Rd, Baker 4, Boston, MA 02215, USA
Chest 132:554-61. 2007..Hospitalized patients with medical illness are especially susceptible to the development of venous thromboembolism (VTE)...
Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physiciansC A Camargo
Division of Preventive Medicine, Brigham and Women s Hospital, Boston, MA 02215 1204, USA
Circulation 95:577-80. 1997..Moderate alcohol consumption decreases the risk of coronary heart disease, but its relation to peripheral arterial disease (PAD) is uncertain...
Abbreviated hospitalization for deep venous thrombosis with the use of ardeparinS Z Goldhaber
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Mass 02115, USA
Arch Intern Med 158:2325-8. 1998..However, this low-molecular-weight heparin has not been previously evaluated in a randomized controlled trial for treatment of established acute deep venous thrombosis...
Time trends in warfarin-associated hemorrhageNils Kucher
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Am J Cardiol 94:403-6. 2004..The proportion of patients with major and intracranial bleeding increased from 20.2% and 1.9%, respectively, in the first time period, to 33.3% and 7.8%, respectively, in the second...
Thrombolytic therapy in pulmonary embolismS Z Goldhaber
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Semin Vasc Med 1:213-20. 2001..7% in clinical trials up to approximately 3.0% in a large registry...
Chest CT assessment following thrombolysis or surgical embolectomy for acute pulmonary embolismFlorian Kipfmueller
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Vasc Med 10:85-9. 2005..33). Reconstructed 4-chamber views on chest CT provide noninvasive imaging of right ventricular enlargement and permit dynamic assessment of the right ventricular response to thrombolysis and embolectomy in patients with acute PE...
Thrombosis during pregnancy and the postpartum periodAndra H James
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710 and Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Boston, MA, USA
Am J Obstet Gynecol 193:216-9. 2005..To describe the circumstances surrounding deep vein thrombosis among pregnant or postpartum patients enrolled in a large multicenter registry...
Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health StudyRobert J Glynn
Division of Preventive Medicine, Brigham and Women s Hospital, 900 Commonwealth Ave E, Boston, MA 02215 1204, USA
Circulation 116:1497-503. 2007..Supplementation with vitamin E may antagonize vitamin K in healthy adults, but it is unclear whether intake of vitamin E decreases the risk of venous thromboembolism (VTE)...
Venous thromboembolism in patients undergoing surgery: low rates of prophylaxis and high rates of filter insertionAli Seddighzadeh
Cardiovascular Division, Brigham and Women s Hospital Boston, MA 02115, USA
Thromb Haemost 98:1220-5. 2007..Future studies should focus on devising mechanisms to improve implementation of prophylaxis and investigate the long-term safety and efficacy of IVC filters in surgical patients...
Electronic alerts to prevent venous thromboembolism among hospitalized patientsNils Kucher
Department of Medicine, Cardiovascular Division, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA
N Engl J Med 352:969-77. 2005..43 to 0.81; P=0.001). CONCLUSIONS: The institution of a computer-alert program increased physicians' use of prophylaxis and markedly reduced the rates of deep-vein thrombosis and pulmonary embolism among hospitalized patients at risk...
Prognostic role of brain natriuretic peptide in acute pulmonary embolismNils Kucher
Cardiovascular Division, Brigham and Women s Hospital, 75 Francis St, Harvard Medical School, Boston, Mass 02115, USA
Circulation 107:2545-7. 2003..Rapid, noninvasive, and accurate prognostic assessment with an inexpensive cardiac biomarker is an appealing approach for patients with acute pulmonary embolism (PE)...
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trialNils Kucher
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Arch Intern Med 165:341-5. 2005..99) and in elderly (1.1% vs 0.7%; P=.12) patients. CONCLUSION: Our findings suggest that a fixed low dose of dalteparin sodium of 5000 U/d is effective and safe in preventing VTE in obese and elderly hospitalized medical patients...
Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trialRobert J Glynn
Brigham and Women s Hospital, Harvard Medical School, and Harvard School of Public Health, Boston, Massachusetts 02215, USA
Ann Intern Med 147:525-33. 2007..Short-term aspirin therapy can lower the risk for venous thromboembolism (VTE) in high-risk patients, but whether the long-term use of low-dose aspirin reduces risk in healthy adults is uncertain...
Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantationJohn Fanikos
Cardiovascular Division, The Department of Pharmacy, and Center for Clinical Excellence, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA
Am J Cardiol 93:247-50. 2004..The patients who received low-molecular-weight heparin had a shorter length of stay and decreased postoperative costs compared with the control subjects receiving unfractionated heparin...
Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approachMarzia Leacche
Division of Cardiac Surgery, and Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA
J Thorac Cardiovasc Surg 129:1018-23. 2005....
Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacementG K Bell
Charles River Associates, Inc, Boston, MA, USA
Vasc Med 6:23-9. 2001..In conclusion, LMWH has the potential to offer several short- and long-term cost advantages compared with warfarin, mostly due to lower test costs associated with prophylaxis and reduced complication rates...
Once daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control studyMelkon Hacobian
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Clin Appl Thromb Hemost 16:21-5. 2010..5 mg/kg once daily versus enoxaparin 1.0 mg/kg twice daily as a bridge to warfarin in outpatients with acute venous thromboembolism...
Massive pulmonary embolismNils Kucher
Cardiovascular Division, Department of Medicine, University Hospital Zurich, Zurich, Switzerland
Circulation 113:577-82. 2006..Counterintuitively, thrombolysis did not reduce mortality or recurrent PE at 90 days. The observed reduction in mortality from IVC filters requires further investigation...
Major bleeding complications in a specialized anticoagulation serviceJohn Fanikos
Department of Pharmacy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Am J Cardiol 96:595-8. 2005..32 bleeds/100 patient-years of coverage. Of the 12 bleeding events, 5 (42%) were intracranial hemorrhages. The average hospitalization cost per patient was dollar 15,988, and the average length of hospitalization was 6.0 days...
Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higherNils Kucher
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Arch Intern Med 165:1777-81. 2005..CONCLUSION: Among patients with pulmonary embolism who present with a systolic arterial pressure greater than or equal to 90 mm Hg, echocardiographic RV hypokinesis is an independent predictor of early death...
Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolismTudor Scridon
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Am J Cardiol 96:303-5. 2005..Patients with elevated troponin and right ventricular enlargement are at significantly greater risk for death after PE than patients with only 1 or with neither adverse prognostic marker...
Thrombolysis for pulmonary embolismSamuel Z Goldhaber
Harvard Medical School, Boston, MA 02115, USA
N Engl J Med 347:1131-2. 2002
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-2004. A 42-year-old woman with cardiac arrest several weeks after an ankle fractureSamuel Z Goldhaber
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, USA
N Engl J Med 350:2281-90. 2004
Clinically significant venous thromboembolism after gynecologic surgeryJ O Schorge
Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women s Hospital, Boston, MA 02115, USA
J Reprod Med 44:669-73. 1999..To review the incidence and outcome of clinically significant venous thromboembolism (VTE) following gynecologic surgery in a population receiving provider-specified prophylaxis...
Optimizing anticoagulant therapy in the management of pulmonary embolismS Z Goldhaber
Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Semin Thromb Hemost 25:129-33. 1999..Recognition of potential causes of excessive anticoagulation and the use of self-monitoring by patients may improve the efficacy and safety of long-term warfarin administration...
Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolismKaren Fiumara
Department of Pharmacy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
Am J Cardiol 97:127-9. 2006..4 to 1,410.9, p < 0.001), cancer (OR 16.0, 95% CI 3.2 to 80, p = 0.004), diabetes mellitus (OR 9.6, 95% CI 1.7 to 54, p = 0.010), and elevated international normalized ratio before fibrinolysis (OR 5.8, 95% CI 1.5 to 22, p = 0.012)...
Routine pelvic and lower extremity CT venography in patients undergoing pulmonary CT angiographyAndetta R Hunsaker
Department of Radiology, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
AJR Am J Roentgenol 190:322-6. 2008..The purpose of our study was to assess the utility of performing routine pelvic and lower extremity CT venography (CTV) along with pulmonary CT angiography (CTA) in all patients evaluated for pulmonary embolism...
Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combinationRanjith Shetty
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA
J Thromb Thrombolysis 26:35-40. 2008..Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for venous thromboembolism (VTE). We analyzed a large US deep vein thrombosis (DVT) registry to explore the profile of patients with COPD and VTE...
Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolismKelly L Dunn
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
J Am Coll Cardiol 40:1475-8. 2002..By paying more attention to normal D-dimer results, fewer chest CT scans and lung scans will be required, and improvements may be realized in diagnostic efficiency and cost reduction...
Acute pulmonary embolectomy: a contemporary approachLishan Aklog
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 02115, USA
Circulation 105:1416-9. 2002..Our contemporary approach to pulmonary embolectomy no longer confines this operation to a treatment of last resort reserved for clinically desperate circumstances...
Few predictors of massive deep vein thrombosisHylton V Joffe
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Thromb Haemost 94:986-90. 2005..02-1.34) was the only independent predictor of massive DVT. Thrombus propagation from the femoropopliteal system cannot be reliably predicted using demographic or clinical characteristics...
Gastrointestinal complications after 3 months of dual antiplatelet therapy for drug-eluting stents as assessed by wireless capsule endoscopyAli Seddighzadeh
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
Clin Appl Thromb Hemost 15:171-6. 2009..Future studies should expand on our observations to determine whether prophylaxis with proton pump inhibitors is warranted...
International normalized ratio increase before warfarin-associated hemorrhage: brief and subtleNils Kucher
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Arch Intern Med 164:2176-9. 2004..CONCLUSIONS: Serial INRs are poor predictors of hemorrhagic events. There appears to be only a brief warning period during which a slightly elevated INR predicts an imminent bleeding event...
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolismNils Kucher
Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Vasc Med 10:251-6. 2005..217). In patients with acute symptomatic PE, extended enoxaparin monotherapy is feasible and warrants further investigation in a large clinical trial...
A prospective study of risk factors for pulmonary embolism in womenS Z Goldhaber
Channing Laboratory, Boston, Mass, USA
JAMA 277:642-5. 1997..To investigate risk factors for pulmonary embolism in women...
Deep-vein thrombosis in the elderlyGregory Piazza
Department of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, 1 Deaconess Road, Boston, MA 02215, USA
Clin Appl Thromb Hemost 14:393-8. 2008..Diagnosis can present a challenge because typical deep-vein thrombosis symptoms may be absent. Fewer than 50% of elderly patients with deep-vein thrombosis had received any venous thromboembolism prophylaxis...
Fibrinolysis for acute pulmonary embolismGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Vasc Med 15:419-28. 2010....
Adherence to pharmacological thromboprophylaxis orders in hospitalized patientsJohn Fanikos
Department of Pharmacy, Brigham and Women s Hospital, Boston, MA 02115, USA
Am J Med 123:536-41. 2010..Our goals were to determine which strategy demonstrated the best adherence in terms of timing and frequency of dose administration, and to determine reasons for ordered heparin not being administered...
Prospective study of BMI and the risk of pulmonary embolism in womenChristopher Kabrhel
Department of Emergency Medicine, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA
Obesity (Silver Spring) 17:2040-6. 2009..Increasing BMI has a strong, linear association with the development of PE in women. Clinicians should consider BMI when assessing the risk of PE in their patients...
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patientsGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Circulation 119:2196-201. 2009....
Pulmonary embolism in heart failureGregory Piazza
Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA
Circulation 118:1598-601. 2008
Long-term complications of medical patients with hospital-acquired venous thromboembolismJohn Fanikos
Department of Pharmacy, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Thromb Haemost 102:688-93. 2009..These VTE complications would be reduced by more than half with universal thromboprophylaxis. Further efforts should focus on improving VTE prophylaxis utilisation...
The contribution of the subjective component of the Canadian Pulmonary Embolism Score to the overall score in emergency department patientsChristopher Kabrhel
Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA 02114, USA
Acad Emerg Med 12:915-20. 2005..However, research suggests that subjective gestalt performs similarly to the CPES, and the influence of the subjective question on the predictive value of the CPES is not clear...
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomyJohn G Byrne
Cardiac Surgery, Brigham and Women s Hospital, 75 Francis Street, Boston, MA, USA
Chest 122:2256-9. 2002..When patients present with dyspnea, hepatojugular reflux, and peripheral edema refractory to diuretics, constrictive cardiac physiology should be considered in the differential diagnosis, even in the absence of parietal pericardium...
Shortness of breath in the postoperative patientHaritha Challapalli
Division of Emergency Medicine, Harvard Medical School, Boston, Massachusetts, USA
J Emerg Med 27:171-7. 2004
Medication errors associated with anticoagulant therapy in the hospitalJohn Fanikos
Department of Pharmacy, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02215, USA
Am J Cardiol 94:532-5. 2004..2% of patients required medical intervention and 1.5% needed prolonged hospitalization. Medication errors frequently occur with anticoagulant therapy in hospitalized patients...
Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolismRene Quiroz
Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
Am J Cardiol 98:535-7. 2006..69). These results should provide clinicians with increased warfarin dosing options in patients presenting with acute venous thromboembolism...
Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulationStacey L Amorosi
Innovus Research Inc, Medford, Massachusetts 02115, USA
Am J Cardiol 93:509-11. 2004..For surgeries requiring an overnight stay, bridging costs are estimated to be 672, 933, and 3,816 US dollars, respectively, for each of these strategies...
Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studiesBrian M Wolpin
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
Thromb Haemost 104:962-71. 2010..04). In two large, prospective cohorts, ABO blood type was significantly associated with the risk of idiopathic and non-idiopathic PE, with even greater risk for idiopathic PE among current and past smokers with non-O blood type...
Heparin-induced thrombocytopenia (HIT): clinical and economic outcomesSteven Baroletti
Department of Pharmacy, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Thromb Haemost 100:1130-5. 2008..Prospective controlled trials need to be conducted to determine the optimal strategy to reduce the frequency of HIT...
A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosisSamuel Z Goldhaber
The Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Am J Cardiol 93:259-62. 2004..Of the 2,726 patients who had their DVT diagnosed while in the hospital, only 1,147 (42%) received prophylaxis within 30 days before diagnosis...
High utilization rate of vena cava filters in deep vein thrombosisMichael R Jaff
Massachusetts General Hospital, 55 Fruit Street, Yawkey Center for Outpatient Care, Room 5938, Boston, Massachusetts 02114, USA
Thromb Haemost 93:1117-9. 2005..Many of these patients may have warranted less invasive methods of venous thromboembolism prophylaxis. Improved physician education regarding mechanical and pharmacologic prophylaxis alternatives might reduce the use of IVCFs...
Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulationDavid M Dorfman
Department of Pathology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
Vasc Med 10:23-7. 2005..Instead, a predefined cut-off range for high INR values generated by POC instruments should mandate confirmatory testing with central laboratory instrumentation...
Clinical gestalt and the diagnosis of pulmonary embolism: does experience matter?Christopher Kabrhel
Department of Emergency Medicine, Massachusetts General Hospital, 55 Fruit St, Clinics Building 115, Boston, MA 02114, USA
Chest 127:1627-30. 2005....
Deep vein thrombosis in orthopedic surgeryMarcella Calfon
Department of Medicine, Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston Massachusetts, USA
Clin Appl Thromb Hemost 15:512-6. 2009..In conclusion, despite having fewer comorbid conditions, orthopedic patients with deep vein thrombosis remain particularly vulnerable to calf deep vein thrombosis. Rates of venous thromboembolism prophylaxis were inadequate...
Venous thromboembolic events in hospitalised medical patientsGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Thromb Haemost 102:505-10. 2009..The number of VTE-related events would be halved with universal thromboprophylaxis. Further efforts focused on improving VTE prevention strategies in hospitalised medical patients are warranted...
The probability of pulmonary embolism is a function of the diagnoses considered most likely before testingChristopher Kabrhel
Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
Acad Emerg Med 13:471-4. 2006....
Physician alerts to prevent venous thromboembolismGregory Piazza
Cardiovascular Division, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Thromb Thrombolysis 30:1-6. 2010..In this review article, we discuss decision support strategies for improving VTE prevention during hospitalization and at the time of discharge...
Prescription of fondaparinux in hospitalised patientsSteven Baroletti
Department of Pharmacy, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
Thromb Haemost 101:1091-4. 2009..Fondaparinux warrants further evaluation in patients with HIT or suspected HIT. In the meantime, its off-label use may exceed its use for FDA-approved indications...
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolismPaul M Ridker
Center for Cardiovascular Disease Prevention and the Division of Preventive Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston 02215, USA
N Engl J Med 348:1425-34. 2003..0 and 3.0. However, for long-term management, no therapeutic agent has shown an acceptable benefit-to-risk ratio...
Electronic alerts for hospitalized high-VTE risk patients not receiving prophylaxis: a cohort studySteven Baroletti
Pharmacy, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
J Thromb Thrombolysis 25:146-50. 2008..The present study evaluated the effects of an electronic alert to the responsible physician in a cohort of hospitalized high-risk patients not receiving VTE prophylaxis...
Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imagingMarcelo F Di Carli
Division of Nuclear Medicine PET, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Nucl Cardiol 14:799-809. 2007..We examined the value of CTA to identify the presence of ischemia, as determined by stress perfusion imaging, using integrated positron emission tomography (PET)-CT imaging...
Time-resolved MR angiography: a primary screening examination of patients with suspected pulmonary embolism and contraindications to administration of iodinated contrast materialHale Ersoy
Cardiovascular Imaging Section, Department of Radiology, Brigham and Women s Hospital and Harvard Medical School, 75 Francis St, ASB I L1 004, Boston, MA 02115, USA
AJR Am J Roentgenol 188:1246-54. 2007..The purpose of this study was to evaluate the efficiency and reproducibility of a single-breath-hold time-resolved 3D MR angiographic technique in the diagnosis of pulmonary embolism...
